Search

Subject Intermediate-risk -- Brachytherapy -- Prostate -- Outcomes -- HDR

1. Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients. (December 2019)

Authors:
Martell, K.; Mendez, L.C.; Chung, H.T.; Tseng, C.L.; Alayed, Y.; Cheung, P.; Liu, S.; Vesprini, D.; Chu, W.; Wronski, M.; Szumacher, E.; Ravi, A.; Loblaw, A.; Morton, G.
Journal:
Radiotherapy and oncology
Issue:
Volume 141(2019)
Page Start:
149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • Intermediate-risk -- Brachytherapy -- Prostate -- Outcomes -- HDR 1